Immunotherapy helped extend the lives of some patients with the most common type of advanced colon cancer, researchers report.
The new findings are important, they noted, because immunotherapy doesn't typically work against microsatellite stable (MSS) colon cancer. These patients have few treatment options once their disease no longer responds to chemotherapy.
Significant fatigue at the start of cancer treatment is associated with a greater risk of severe side effects and shorter survival, a new study finds.
Researchers analyzed data from four clinical trials of lung cancer or prostate cancer treatments that were conducted by the SWOG Cancer Research Network, a cancer clinical trials group funded by the U.S. National Cancer Institute.
After being diagnosed with bladder cancer, some patients face an almost impossible decision -- have their bladder removed or take a risk knowing that the cancer may be more likely to spread if the bladder is left intact.
But what if there was another way?
For David Cabelis, 68, the decision was more straightforward than most, as he had a unique opportunity to take part in a clinical...
A small but significant percentage of Americans take medications that can hamper their immune system and its response to COVID-19 vaccines, researchers say.
Their analysis of data from more than 3 million adults under 65 with private insurance found that nearly 3% take immunosuppressive drugs. Those include chemotherapy medications and steroids such as prednisone.
Early in the pandemic, some were concerned that breast cancer treatments that weaken the immune system might increase a person's risk of catching or dying from COVID-19.
Now, new research shows that women who have these treatments are no more likely to become sick from the novel coronavirus or to die from it than women being treated with other cancer treatments that do not weaken immune d...
As the COVID-19 pandemic unfolded, breast cancer experts realized space in operating rooms and hospitals could become scarce. That meant rethinking standard care, to provide the best way to treat patients under these suddenly restricted conditions.
One of the new ideas: Reverse the order of care given to patients with a type of breast cancer known as estrogen receptor-positive (ER+). ER+ ...
A cutting-edge experimental drug cuts nearly in half the risk of death among patients with a rare but aggressive cancer of the eye, new clinical trial data show.
Tebentafusp has now become the first drug shown to improve overall survival in patients with uveal melanoma, said Dr. Antoni Ribas, immediate past president of the American Association of Cancer Research (AACR), in a
Angie Gaytan never cared much for beets, but beets sure do love her -- doctors say that veggie shakes, fruits, beet juice and other healthy foods likely helped the 16-year-old defeat her life-threatening leukemia.
Such a healthy diet helped more than Angie: A new study found that adopting a low-fat, low-sugar diet appeared to boost the effectiveness of chemotherapy in a group of 40 childr...
Women with advanced ovarian cancer often face grim statistics, with less than half surviving for five years after their diagnosis. However, a new study suggests that so-called "maintenance therapy" with a targeted cancer drug may add years to some patients' lives.
In findings described by some experts as "remarkable," the study showed that women with advanced ovarian cancer linked to the ...
Stem cell transplants may have long-lasting benefits for some people with aggressive cases of multiple sclerosis, a new study suggests.
Italian researchers found that among 210 multiple sclerosis (MS) patients who received a stem cell transplant -- with cells from their own blood -- two-thirds saw no worsening in their disability 10 years out.
Women with advanced breast cancer who undergo surgery to remove the tumor after chemotherapy or another type of systemic treatment may live longer than those who don't have surgery, a new study suggests.
The findings challenge a long-held belief that surgery confers little benefit for women with stage 4 breast cancer unless the cancer is causing pain, bleeding or other symptoms. Stage 4 i...
More women with early-stage breast cancer may be able to safely skip chemotherapy after having surgery, according to initial results from a major clinical trial.
The trial, conducted in nine countries, found that adding chemotherapy to hormone-blocking drugs brought no added benefit to a particular group of patients. Those were postmenopausal women with hormone-sensitive breast cancer tha...
When a young woman is diagnosed with breast cancer, many questions go through her mind.
What treatments does she need? Will she survive? And will she still be able to have a baby?
In a review of recent research, an international team of investigators say the answer to that critical third question is yes. Though breast cancer survivors are less likely to become pregnant than the ave...
Christina Kosyla, a drama and yoga teacher in her late 20s, was about to take the trip of a lifetime when she felt a strange twinge in her shoulder. A co-worker also pointed out some slight swelling in Kosyla's shoulder.
Kosyla and her best friend were planning to hike the Camino De Santiago -- a 500-mile pilgrimage from France to Spain that required exceptional physical fitness and ...
A combination of chemotherapy and immunotherapy may slow the progress of metastatic bladder cancer and extend survival, a clinical trial suggests.
Current treatment for advanced bladder cancer is chemotherapy, but adding the immunotherapy drug atezolizumab (Tecentriq) appears to help more patients fight this disease. It strikes 81,000 Americans a year and kills 18,000.
Cholesterol-lowering statins are commonly used to help prevent heart disease. Now a new study hints that they could shield women's hearts from the harms of certain breast cancer drugs.
The study focused on women in Canada who'd been treated with either chemotherapy drugs called anthracyclines or the medication Herceptin. Though the treatments can be lifesaving, they can also damage th...
New treatments for melanoma have dramatically reduced deaths from this often fatal skin cancer.
Leaders of a new study report that the death rate from aggressive melanoma that spread to other organs plummeted 18% between 2013 and 2016, after jumping 7.5% between 1986 and 2013. The figures apply to white Americans, the group that accounts for nearly all cases of melanoma in th...
Many people don't realize that cancer patients are in constant need of blood supplies.
Chemotherapy and radiation treatments for cancer can damage the body's ability to produce healthy blood cells and cause potentially life-threatening conditions. Blood transfusions help provide critical clotting factors, proteins and antibodies.
Chemotherapy can be hard on the heart, but an individualized exercise program may mitigate some of that damage, new research suggests.
Heart problems are a common side effect in patients with cancer because cancer treatments can impair heart function and structure or accelerate development of heart disease, especially when patients have risk factors such as high blood pressure, accor...
Early treatment with an immune-boosting therapy might improve the outlook of young children with an advanced form of cancer, a new small study suggests.
The trial involved 43 children with high-risk neuroblastoma, a cancer that starts in immature nerve cells. Researchers found that a new treatment approach -- involving an experimental antibody given right off the bat -- started to qui...
The treatments that childhood cancer patients receive often save their lives, but they also make survivors prone to heart troubles, a new study finds.
For the study, researchers examined heart disease rates in nearly 7,300 childhood cancer survivors (diagnosed at an average age of 7) and a "control group" of more than 36,000 people without cancer in the province of Ontario, Canada.
Could the DNA from a patient's breast tumor help doctors spot whether stray cancer cells are still in her blood?
That's what a small, new study suggests is possible. If the findings are replicated in a larger study, such a test might help determine whether a treatment is working or not. It also has the potential to reduce unnecessary additional treatments for breast cancer.
Glioblastoma brain cancer remains one of deadliest tumors, and new research shows five-year survival rates remain low for patients with the disease.
While there have been improvements in short- and medium-term survival rates for patients with the most common type of brain tumor in adults, only 6% of patients live for five years after diagnosis, according to the Mayo Clinic researc...
New research should reassure dads-to-be who've had testicular cancer that treatment with radiation or chemotherapy doesn't raise the risk of fathering babies with birth defects.
"Our research set out to investigate whether treatment for the most common cancer among young men leads to a higher risk of fathering a child with a birth defect and we saw no increased risk associated with ca...
Learning you have a cancer that looks imminently terminal is tough news to swallow.
And new research indicates that when given just one month to live, a significant number of patients still opt for aggressive and often costly interventions, despite little evidence to suggest they'll help.
A study of just over 100,000 patients in the United States found that the urge to under...
Scientists say they have used frozen testicular tissue to achieve the birth of a healthy baby monkey named Grady -- a success they hope to eventually translate to childhood cancer survivors whose treatment has left them infertile.
Infertility is a potential side effect of the chemotherapy and radiation used to treat various can...
It's one of the toughest cancers to beat. But new research suggests that identifying the genetics of pancreatic cancer in individual patients could boost survival for some.
The five-year survival rate for pancreatic cancer patients is less than 9 percent. One reason this cancer is so deadly is that many patients are diagnosed at a late stage and often with inoperable tumors.
Even when women have health insurance, high deductibles may delay them from having breast cancer diagnosed and treated, researchers say.
In a study of more than 3 million U.S. women with health insurance, the researchers found that those in plans with high deductibles waited several months more for a breast cancer diagnosis or treatment, versus women in low-deductible plans.
Deceased people who are cremated after having been treated with radioactive medications might be a health hazard to crematory operators, a new case study shows.
An Arizona crematorium became contaminated with radiation following the cremation of a man who received "radiopharmaceutical" treatment two days before he died, according to a research letter published Feb. 26 in the Journ...